about
Design and construction of a new human naïve single-chain fragment variable antibody library, IORISS1.CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling.Emerging drugs for high-grade osteosarcoma.Process development of a human recombinant diabody expressed in E. coli: engagement of CD99-induced apoptosis for target therapy in Ewing's sarcoma.CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin.Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines.Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines.Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma.4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a promising new candidate for chemotherapeutic treatment of osteosarcoma patients.Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcoma.High doses of glucosamine-HCl have detrimental effects on bovine articular cartilage explants cultured in vitro.Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques.Effects of physical stimulation with electromagnetic field and insulin growth factor-I treatment on proteoglycan synthesis of bovine articular cartilage.Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.CD99 at the crossroads of physiology and pathology.CD99: A Cell Surface Protein with an Oncojanus Role in Tumors.Insulin-like growth factor 2 mRNA-binding protein 3 is a novel post-transcriptional regulator of Ewing sarcoma malignancy.Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy.Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1R.A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma TherapyConstruction of Human Naïve Antibody Gene LibrariesGenetic analysis of fibrosarcoma of bone, a rare tumour entity closely related to osteosarcoma and malignant fibrous histiocytoma of bone
P50
Q35946569-16105268-C70A-4690-B2EC-6BA86B4657C7Q37694869-EECA1DED-0B37-4467-BD27-133A8F1FAA94Q37778400-073DE33F-6492-4C8D-BB07-BB3786E9231BQ38810472-04CB895F-5299-47A4-83EB-BA1E9E189DBBQ38929303-6E69C452-F83C-48B7-ACA9-DEC55D7F2E18Q39446187-14B2CE4B-55D0-4FE9-B3A1-C9FCEFEB1C81Q39902204-3E6118A6-3F37-4EFA-AF7B-0B9BB45A0226Q39995579-D35C00F1-C187-4619-A614-78D5295E8825Q40378150-EFEE7BBC-9A91-4154-ADDA-21AE82330A52Q40417879-82891230-4FEE-4F04-8366-6BCEB4D2ACA5Q44163880-9C7B0CF3-9402-4195-A797-0CE36FD8F0EEQ44634672-0FE86EE9-8E7C-4A05-A0E1-4E811E06ACBDQ45079862-C783C70A-A498-45E6-A2F7-DEF797BFF382Q46431085-D32B438A-49E5-4D29-80AE-C00B18561C1FQ47203268-727D2E2F-964D-43FB-9347-9A024260DAFBQ52658031-BF7735FA-C0A5-40AF-80A3-1905517B2C51Q52716117-452EE2AE-04A0-42C8-8917-3EB1CDE3F912Q53240644-7455B479-4B18-42B2-9E96-58E9AC613E0BQ53687227-86B37F9F-319B-4F8A-9FB1-FC8D1BA45804Q56378218-C8F9916D-B414-452A-B8A1-B069653133A4Q56889773-9771FF58-E0A5-416A-B687-2DEF7E0E8B2EQ57001391-DAFAFB16-6551-409F-AA1C-5467D9009BAC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michela Pasello
@ast
Michela Pasello
@en
Michela Pasello
@es
Michela Pasello
@nl
type
label
Michela Pasello
@ast
Michela Pasello
@en
Michela Pasello
@es
Michela Pasello
@nl
prefLabel
Michela Pasello
@ast
Michela Pasello
@en
Michela Pasello
@es
Michela Pasello
@nl
P106
P1153
6507813614
P31
P496
0000-0002-2020-9376